October, 2016
Partager Partager Partager Partager

Genopole Grounds Extension Selected by the Métropole Grand Paris

Genopole is proud to announce that its biocluster is one of the 61 sites selected within the framework of the architectural and urban call for projects “Inventing the Grand Paris Metropole”, designed to promote innovative projects in the area (Inventons la Métropole du Grand Paris). The announcement was made on October 10 by the Métropole Grand Paris, which brings together Paris and 131 towns from the inner suburbs and greater Paris area.
Genopole - Métropole Grand Paris
By the year 2025, Genopole forecasts a major development of its operations around four key strategic areas: precision medicine, regenerative medicine, gene therapy and synthetic biology. In order to raise both its national and international profile, attract new innovative companies and create more jobs, Genopole will be able to rely on additional real estate.

On the occasion, on August 30, of the visit to Genopole by Patrick Ollier, President of the Métropole du Grand Paris, Francis Chouat, President of Grand Paris Sud supported the project put forward by Pierre Tambourin, CEO of Genopole, and Michel Bernard, President of the Sem Genopole, in charge of managing the biocluster’s property assets. Close to the campus, the grounds selected will enable the campus to increase its capacity over 4,000 sq.m..
Algama expands to the US

To grow its business in France and abroad, ALGAMA has raised €3.5 million in a first round of investments, with the Hong Kong fund Horizons Ventures becoming a reference shareholder in the start-up.

The funds raised will enable ALGAMA to scale up the R&D work at its FoodLab in Genopole and to attract new talent while extending its global operations. ALGAMA's business development activities are now being conducted not only in Paris but also (since March 2016) in New York.
The support of Horizons Ventures will enable ALGAMA to strengthen its partnerships and consolidate its leading position in the field of microalgae development.
Read more {...} read more

GLOBAL BIOENERGIES joins PREEM, SEKAB and SVEASKOG in the “bio-based gasoline project” in Sweden

GLOBAL BIOENERGIES (Alternext Paris: ALGBE), PREEM, SEKAB and SVEASKOG announce having joined forces to develop a high-performance fuel entirely based on forest resources.
The consortium has signed a collaboration agreement to carry out a conceptual scope study for a first plant in Sweden. This work will be carried out as part of the “Bio-Based Gasoline Project” with support from the Swedish Energy Agency.

In April this year, Preem, Sekab and Sveaskog had announced having entered into a collaboration to develop a gasoline fuel based entirely on forest resources with support from the Swedish Energy Agency. The consortium has selected the Isobutene process developed by the French industrial biotech Global Bioenergies for the conversion of wood derived sugars into high performance gasoline.

With close to 30 million hectares of forest land (14% of which being owned and managed by Sveaskog), Sweden positions itself as a leader in the sustainable supply of resources for the energy transition. To reduce the country’s dependence on fossil transport fuels and maximize regional impact, state-of-the-art technological solutions must be implemented to convert this natural wealth in ready-to-use, easy to ship high performance sustainable fuels.
Read more {...} read more
  Science en Direct

The Fête de la Science Celebrates 25 Years of Success

2016 marks the 25th anniversary of the Fête de la Science, a festive week involving major French research organizations such as the INSERM and the CNRS, as well as the University of Evry and Genopole. This year’s edition kicked off at the Cité des Sciences in Paris, hosted by a French TV presenter famous for his weekly show introducing young people to science.
At the Cité des Sciences, Pierre Tambourin participated in a debate on precision medicine. The start-up Glowee was also present offering an experiment around bioinspiration. As well as the interactive conferences shown live on the websites of participating organizations, the public was able to partake in a series of demonstrations throughout the weekend, which, given the constant flow of people, were a major success.
  Fête de la science 2016
The weekend was followed by 5 days of public events spread over the Evry area. The University of Evry was honoured to welcome a great public speaker, Raphaël Haumont, a physicochemical researcher who, along with notorious French Chef Thierry Marx, created the Centre Français d’Innovation Culinaire, a thinking tank and testing centre working on the food of the future. Close to 2,000 participants, both big and small, were able to attend conferences, with the Ynsect session a great success, to participate in demonstrations, and to visit a variety of laboratories.
In particular, the visit of the Genopole incubator was among students’ favourites, including drinking Algama’s blue water made from seaweed, and DNA testing at Anova-Plus. The Généthon and Genoscope workshops (open to a younger public), were also among the many successes that justify the existence of the Fête de la Science for a quarter of a century!


Genopole is pleased to welcome two new companies on its campus: Arianne Clinical and AATI.

Established in 2005, Arianne Clinical is a CRO that was initially based in San Diego. They are now globally present: not only in North America but also in Africa, Asia and Europe. Arianne offers scientific expertise in clinical and non-clinical development, US and international clinical operations, and strategic regulatory guidance. Most recently, they have decided to base their European operations at Genopole.
Arianne Corp
AATI AATI Expands International Operations With French Subsidiary.
Advanced Analytical Technologies, Inc. is excited to announce their expansion into France with the opening of their French subsidiary, Advanced Analytical Technologies, SARL. The new office was established in the Genopole biocluster, for its ideal location, as it hosts companies and researchers who are at the forefront of molecular biology and genomics research in France. AATI SARL will provide direct sales and technical support to AATI customers in France and the French speaking part of Belgium and Luxembourg. To learn more about the opening of AATI SARL, click here.

AURP International Conference – Genopole On Stage

Genopole was present at the 2016 Annual International Conference of the AURP (Association of University Research Parks) that was held in Oklahoma City from 27 to 30 September. This year’s Conference was hosted by the University of Oklahoma Research Campus and the Greater Oklahoma City Chamber and drew industry experts and research park leaders from across the U.S. and internationally. Its theme was “Harnessing the Winds of Change: Pioneering the Future of Ingenuity at University Research Parks”.

AURP International conference
Genopole’s Director of International Affairs, Dr. Denis Gauvreau, presented in the session entitled “Collaborating with Networks Outside North America”.

Read more about the mission {...} read more

Rendez-vous CARNOT 2016 - Laurent & Hélène

Genopole Networking at the Rendez-vous Carnot

Rendez–vous Carnot is an annual event that enables companies with an R&D project to meet with potential public or private partners. For two days, over 9,000 business meetings take place. On the Genopole stand, cluster representatives had very interesting meetings with Technology Transfer offices, start-ups, big companies, and research institutes, in particular from the Carnot institute networks.
These meetings enabled us to discuss possible collaborations. The Rendez-vous Carnot also selected a few start-ups to pitch in front of the audiences including two Genopole companies (Traaser and Lab Assistant).

Synthetic Biology: from Ideas to Market

Synthetic biology stands among the major scientific advancements of the last decade and offers a wide range of industrial applications and new production techniques. With this in mind, Genopole - in partnership with TWB and IAR - is organizing on December 6 a colloquium entitled “Synthetic Biology: from Ideas to Market” to explore this promising sector.

There is still time to register!
Colloque Synthetic biology
French tech Ticket 2016
French Tech Ticket & Young Biotech Award - Selection Under Way

After a successful first edition, the French Tech Ticket program is back for 2017 with 41 partner incubators from all over France, including Genopole, ready to welcome international start-ups.
While 23 start-up projects (out of 722 applications) were awarded a French Tech Ticket in 2016, 70 projects will be selected this year.

Call for applications ended on June 21st.

Genopole’s team has been carefully reviewing more than 50 applications over the past few weeks. The awarded projects will be revealed in December. We can’t wait to welcome a few of them to Genopole!
French tech Ticket 2016
Young Biotech Award

The 6th edition of the Young Biotech Award is moving to the next phase: the applicants’ dossiers are all in and currently under review.
After a first selective cut, the most promising candidates will be called for the Entrepreneur Seminar next month.

Stay tuned for more updates in the next newsletter!

  For additional information, write to